ArticleImmunity2012
NK cell genesis: a trick of the trail.
Article in Immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Docosahexaenoic acid supplementation represses the early immune response against murine cytomegalovirus but enhances NK cell effector function.BMC immunology · 2022Article
- Hematopoietic-Specific Deletion of Foxo1 Promotes NK Cell Specification and Proliferation.Frontiers in immunology · 2019Article
- Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function.Nature communications · 2018Article
- FHL2 Regulates Natural Killer Cell Development and Activation duringFrontiers in immunology · 2017Article
- NK cell development in bone marrow and liver: site matters.Genes and immunity · 2014Article
- Mouse natural killer cell development and maturation are differentially regulated by SHIP-1.Blood · 2012Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this issue of Immunity, Gordon et al. (2012) analyzed the role of the transcription factors T-bet and Eomesodermin in natural killer (NK) cell development, revealing a distinct spatiotemporal requirement of these factors for NK cell maturation.
Identifiers
22284412What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.